BackGolden Ally Lifetech Group Overview

Golden Ally Lifetech Group EBIT

Latest ebit for AQPW: $-2.3M, below the sector sector average of $2.4T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$2.02M
↓ 1912.51% YoY

As of Mar 31, 2022

Annual EBIT (TTM)

-$2.28M
↓ 537.04% YoY

Trailing 12 months ending Mar 31, 2022

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Golden Ally Lifetech Group (AQPW) FAQ

As of the most recent data (March 2022), AQPW shows a EBIT of $-2.3M. That compares with $-360K in the prior-year period — down 537.0% year over year. That is below the sector sector average of $2.4T. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, AQPW's EBIT is now $-2.3M (was $-360K) — a 537.0% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Golden Ally Lifetech Group is outperforming or lagging.

The its sector sector average EBIT is about $2.4T. Golden Ally Lifetech Group is at $-2.3M, which is lower that average. That is roughly 100.0% below the sector mean. Use the comparison chart on this page to see how AQPW stacks up against individual peers as well.

Tracking AQPW's ebit over time shows whether Golden Ally Lifetech Group is scaling, shrinking, or reshaping that part of the business. The current reading is $-2.3M That compares with $-360K in the prior-year period — down 537.0% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this ebit page, Stockcircle has Golden Ally Lifetech Group's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect EBIT (currently $-2.3M) with ownership activity and broader fundamentals.